Characterization of H3K9me3- and H4K20me3-associated circulating nucleosomal DNA by high-throughput sequencing in colorectal cancer

Modified histone tails in nucleosomes circulating in the blood bear the potential as cancer biomarkers. Recently, using chromatin immunopecipitation (ChIP)-related quantitative PCR, we described reduced plasma levels of the two pericentric heterochromatin-specific histone methylation marks H3K9me3 a...

Full description

Saved in:
Bibliographic Details
Published inTumor biology Vol. 34; no. 1; pp. 329 - 336
Main Authors Gezer, Ugur, Üstek, Duran, Yörüker, Ebru E., Cakiris, Aris, Abaci, Neslihan, Leszinski, Gloria, Dalay, Nejat, Holdenrieder, Stefan
Format Journal Article
LanguageEnglish
Published Dordrecht Springer Netherlands 01.02.2013
Springer Nature B.V
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Modified histone tails in nucleosomes circulating in the blood bear the potential as cancer biomarkers. Recently, using chromatin immunopecipitation (ChIP)-related quantitative PCR, we described reduced plasma levels of the two pericentric heterochromatin-specific histone methylation marks H3K9me3 and H4K20me3 in patients with colorectal cancer (CRC). Here, by utilizing ChIP-related high-throughput sequencing, we further characterized these modifications in circulation. Plasma DNA from nucleosomes immunoprecipitated by H3K9me3- and H4K20me3-specific antibodies from patients with CRC ( N  = 15) and healthy subjects ( N  = 15) was subjected to the Roche 454 FLX sequencing, and the generated array of ChIP-enriched sequences were compared to the human reference genome. The total number of nucleosomes, of sequence reads and of diverse DNA repetitive elements were statistically compared between the study groups. Total nucleosome amount was not different in both groups. Concerning both histone modifications, lower numbers of sequence reads were detected in CRC patients as compared with healthy controls (medians in H3K9me3: 32 vs. 61; p  < 0.01; in H4K20me3: 54 vs. 88; p  < 0.01). Size of fragments was not different in both groups. Most abundant sequences were repetitive LINE and SINE elements while simple repeats, LTR, DNA, SAT, and low complexity elements were less frequent. Best discrimination between both groups was achieved by total number of H3K9me3 reads (AUC 0.90) and H3K9me3 LINE elements L1 (AUC 0.93) und L2 (AUC 0.91). The present results confirm earlier findings of lower H3K9me3 levels in CRC and show LINE elements to be the most frequent and best discriminative markers on modified histones.
AbstractList Modified histone tails in nucleosomes circulating in the blood bear the potential as cancer biomarkers. Recently, using chromatin immunopecipitation (ChIP)-related quantitative PCR, we described reduced plasma levels of the two pericentric heterochromatin-specific histone methylation marks H3K9me3 and H4K20me3 in patients with colorectal cancer (CRC). Here, by utilizing ChIP-related high-throughput sequencing, we further characterized these modifications in circulation. Plasma DNA from nucleosomes immunoprecipitated by H3K9me3- and H4K20me3-specific antibodies from patients with CRC ( N  = 15) and healthy subjects ( N  = 15) was subjected to the Roche 454 FLX sequencing, and the generated array of ChIP-enriched sequences were compared to the human reference genome. The total number of nucleosomes, of sequence reads and of diverse DNA repetitive elements were statistically compared between the study groups. Total nucleosome amount was not different in both groups. Concerning both histone modifications, lower numbers of sequence reads were detected in CRC patients as compared with healthy controls (medians in H3K9me3: 32 vs. 61; p  < 0.01; in H4K20me3: 54 vs. 88; p  < 0.01). Size of fragments was not different in both groups. Most abundant sequences were repetitive LINE and SINE elements while simple repeats, LTR, DNA, SAT, and low complexity elements were less frequent. Best discrimination between both groups was achieved by total number of H3K9me3 reads (AUC 0.90) and H3K9me3 LINE elements L1 (AUC 0.93) und L2 (AUC 0.91). The present results confirm earlier findings of lower H3K9me3 levels in CRC and show LINE elements to be the most frequent and best discriminative markers on modified histones.
Modified histone tails in nucleosomes circulating in the blood bear the potential as cancer biomarkers. Recently, using chromatin immunopecipitation (ChIP)-related quantitative PCR, we described reduced plasma levels of the two pericentric heterochromatin-specific histone methylation marks H3K9me3 and H4K20me3 in patients with colorectal cancer (CRC). Here, by utilizing ChIP-related high-throughput sequencing, we further characterized these modifications in circulation. Plasma DNA from nucleosomes immunoprecipitated by H3K9me3- and H4K20me3-specific antibodies from patients with CRC (N=15) and healthy subjects (N=15) was subjected to the Roche 454 FLX sequencing, and the generated array of ChIP-enriched sequences were compared to the human reference genome. The total number of nucleosomes, of sequence reads and of diverse DNA repetitive elements were statistically compared between the study groups. Total nucleosome amount was not different in both groups. Concerning both histone modifications, lower numbers of sequence reads were detected in CRC patients as compared with healthy controls (medians in H3K9me3: 32 vs. 61; p<0.01; in H4K20me3: 54 vs. 88; p<0.01). Size of fragments was not different in both groups. Most abundant sequences were repetitive LINE and SINE elements while simple repeats, LTR, DNA, SAT, and low complexity elements were less frequent. Best discrimination between both groups was achieved by total number of H3K9me3 reads (AUC 0.90) and H3K9me3 LINE elements L1 (AUC 0.93) und L2 (AUC 0.91). The present results confirm earlier findings of lower H3K9me3 levels in CRC and show LINE elements to be the most frequent and best discriminative markers on modified histones.[PUBLICATION ABSTRACT]
Modified histone tails in nucleosomes circulating in the blood bear the potential as cancer biomarkers. Recently, using chromatin immunopecipitation (ChIP)-related quantitative PCR, we described reduced plasma levels of the two pericentric heterochromatin-specific histone methylation marks H3K9me3 and H4K20me3 in patients with colorectal cancer (CRC). Here, by utilizing ChIP-related high-throughput sequencing, we further characterized these modifications in circulation. Plasma DNA from nucleosomes immunoprecipitated by H3K9me3- and H4K20me3-specific antibodies from patients with CRC (N=15) and healthy subjects (N=15) was subjected to the Roche 454 FLX sequencing, and the generated array of ChIP-enriched sequences were compared to the human reference genome. The total number of nucleosomes, of sequence reads and of diverse DNA repetitive elements were statistically compared between the study groups. Total nucleosome amount was not different in both groups. Concerning both histone modifications, lower numbers of sequence reads were detected in CRC patients as compared with healthy controls (medians in H3K9me3: 32 vs. 61; p<0.01; in H4K20me3: 54 vs. 88; p<0.01). Size of fragments was not different in both groups. Most abundant sequences were repetitive LINE and SINE elements while simple repeats, LTR, DNA, SAT, and low complexity elements were less frequent. Best discrimination between both groups was achieved by total number of H3K9me3 reads (AUC 0.90) and H3K9me3 LINE elements L1 (AUC 0.93) und L2 (AUC 0.91). The present results confirm earlier findings of lower H3K9me3 levels in CRC and show LINE elements to be the most frequent and best discriminative markers on modified histones.
Modified histone tails in nucleosomes circulating in the blood bear the potential as cancer biomarkers. Recently, using chromatin immunopecipitation (ChIP)-related quantitative PCR, we described reduced plasma levels of the two pericentric heterochromatin-specific histone methylation marks H3K9me3 and H4K20me3 in patients with colorectal cancer (CRC). Here, by utilizing ChIP-related high-throughput sequencing, we further characterized these modifications in circulation. Plasma DNA from nucleosomes immunoprecipitated by H3K9me3- and H4K20me3-specific antibodies from patients with CRC (N = 15) and healthy subjects (N = 15) was subjected to the Roche 454 FLX sequencing, and the generated array of ChIP-enriched sequences were compared to the human reference genome. The total number of nucleosomes, of sequence reads and of diverse DNA repetitive elements were statistically compared between the study groups. Total nucleosome amount was not different in both groups. Concerning both histone modifications, lower numbers of sequence reads were detected in CRC patients as compared with healthy controls (medians in H3K9me3: 32 vs. 61; p < 0.01; in H4K20me3: 54 vs. 88; p < 0.01). Size of fragments was not different in both groups. Most abundant sequences were repetitive LINE and SINE elements while simple repeats, LTR, DNA, SAT, and low complexity elements were less frequent. Best discrimination between both groups was achieved by total number of H3K9me3 reads (AUC 0.90) and H3K9me3 LINE elements L1 (AUC 0.93) und L2 (AUC 0.91). The present results confirm earlier findings of lower H3K9me3 levels in CRC and show LINE elements to be the most frequent and best discriminative markers on modified histones.Modified histone tails in nucleosomes circulating in the blood bear the potential as cancer biomarkers. Recently, using chromatin immunopecipitation (ChIP)-related quantitative PCR, we described reduced plasma levels of the two pericentric heterochromatin-specific histone methylation marks H3K9me3 and H4K20me3 in patients with colorectal cancer (CRC). Here, by utilizing ChIP-related high-throughput sequencing, we further characterized these modifications in circulation. Plasma DNA from nucleosomes immunoprecipitated by H3K9me3- and H4K20me3-specific antibodies from patients with CRC (N = 15) and healthy subjects (N = 15) was subjected to the Roche 454 FLX sequencing, and the generated array of ChIP-enriched sequences were compared to the human reference genome. The total number of nucleosomes, of sequence reads and of diverse DNA repetitive elements were statistically compared between the study groups. Total nucleosome amount was not different in both groups. Concerning both histone modifications, lower numbers of sequence reads were detected in CRC patients as compared with healthy controls (medians in H3K9me3: 32 vs. 61; p < 0.01; in H4K20me3: 54 vs. 88; p < 0.01). Size of fragments was not different in both groups. Most abundant sequences were repetitive LINE and SINE elements while simple repeats, LTR, DNA, SAT, and low complexity elements were less frequent. Best discrimination between both groups was achieved by total number of H3K9me3 reads (AUC 0.90) and H3K9me3 LINE elements L1 (AUC 0.93) und L2 (AUC 0.91). The present results confirm earlier findings of lower H3K9me3 levels in CRC and show LINE elements to be the most frequent and best discriminative markers on modified histones.
Author Holdenrieder, Stefan
Cakiris, Aris
Abaci, Neslihan
Leszinski, Gloria
Üstek, Duran
Dalay, Nejat
Gezer, Ugur
Yörüker, Ebru E.
Author_xml – sequence: 1
  givenname: Ugur
  surname: Gezer
  fullname: Gezer, Ugur
  email: ugurd@istanbul.edu.tr
  organization: Department of Basic Oncology, Istanbul University Oncology Institute, Capa
– sequence: 2
  givenname: Duran
  surname: Üstek
  fullname: Üstek, Duran
  organization: Institute of Experimental Medicine, Istanbul University
– sequence: 3
  givenname: Ebru E.
  surname: Yörüker
  fullname: Yörüker, Ebru E.
  organization: Department of Basic Oncology, Istanbul University Oncology Institute, Capa
– sequence: 4
  givenname: Aris
  surname: Cakiris
  fullname: Cakiris, Aris
  organization: Institute of Experimental Medicine, Istanbul University
– sequence: 5
  givenname: Neslihan
  surname: Abaci
  fullname: Abaci, Neslihan
  organization: Institute of Experimental Medicine, Istanbul University
– sequence: 6
  givenname: Gloria
  surname: Leszinski
  fullname: Leszinski, Gloria
  organization: Institute of Clinical Chemistry, University Hospital Munich
– sequence: 7
  givenname: Nejat
  surname: Dalay
  fullname: Dalay, Nejat
  organization: Department of Basic Oncology, Istanbul University Oncology Institute, Capa
– sequence: 8
  givenname: Stefan
  surname: Holdenrieder
  fullname: Holdenrieder, Stefan
  email: Stefan.Holdenrieder@uni-bonn.de
  organization: Institute of Clinical Chemistry, University Hospital Munich, Institute of Clinical Chemistry and Pharmacology, University Hospital Bonn
BackLink https://www.ncbi.nlm.nih.gov/pubmed/23086575$$D View this record in MEDLINE/PubMed
BookMark eNqF0U-P1CAYBnBi1rh_9AN4MSRevKAvUEp73MyqY3ajFz03DH07ZdPCCPSwXv3iUmc1ZhP1BCS_B17ynJMTHzwS8pzDaw6g3yQuhdYMuGCgVMXUI3LGKyEZyAZOyh44sEo08pScp3QLwFXb1k_IqZDQ1EqrM_J9M5pobMbovpnsgqdhoFt53c4oGTW-p9vqWsB6MikF60zGnloX7TIV7_fUL3bCkMJsJnr18ZLu7ujo9iPLYwzLfjwsmSb8uqC3q3ae2jCFiDYXb423GJ-Sx4OZEj67Xy_Il3dvP2-27ObT-w-byxtmK1CZabuz2KKQpuK6NkLxdpAWYKfa2kDb46CattF1b6qe942VdaGDVKhQ9AJbeUFeHe89xFAGSrmbXbI4TcZjWFLHJVe1EFUN_6dCSw2gQBf68gG9DUv05SOr4k1Trq2KenGvlt2MfXeIbjbxrvvVRAH8CGwMKUUcfhMO3dp2d2y7K213a9vdmtEPMtblny3maNz0z6Q4JlN5xe8x_jH0X0M_AAEbvJY
CitedBy_id crossref_primary_10_1098_rsob_200119
crossref_primary_10_3390_cancers9010005
crossref_primary_10_1080_00365521_2017_1299212
crossref_primary_10_3390_diagnostics12040870
crossref_primary_10_1515_medgen_2023_2065
crossref_primary_10_1053_j_gastro_2015_07_011
crossref_primary_10_1016_j_cca_2020_12_008
crossref_primary_10_1016_j_jncc_2022_09_002
crossref_primary_10_1080_15592294_2017_1300729
crossref_primary_10_1111_febs_15707
crossref_primary_10_1038_s41587_020_00775_6
crossref_primary_10_3389_fcell_2021_622459
crossref_primary_10_1016_j_bbrc_2014_08_002
crossref_primary_10_1016_j_lungcan_2020_07_023
crossref_primary_10_1038_s41575_019_0230_y
crossref_primary_10_1586_17474124_2014_924397
crossref_primary_10_18632_oncotarget_12751
crossref_primary_10_3390_cancers10040101
crossref_primary_10_1016_j_cancergen_2017_11_001
crossref_primary_10_3390_ijms161226180
crossref_primary_10_5217_ir_2023_00115
crossref_primary_10_38079_igusabder_1105142
crossref_primary_10_1186_1471_2407_14_531
crossref_primary_10_3390_pathogens5010018
crossref_primary_10_4331_wjbc_v6_i4_333
crossref_primary_10_1007_s12253_019_00663_8
crossref_primary_10_1055_s_0042_1757404
crossref_primary_10_1038_s41598_022_19174_9
crossref_primary_10_1515_labmed_2022_0030
crossref_primary_10_25122_jml_2023_0269
crossref_primary_10_1016_j_bbadis_2022_166512
crossref_primary_10_1016_j_it_2023_03_005
crossref_primary_10_3171_2019_6_PEDS19259
crossref_primary_10_3390_diagnostics12092147
crossref_primary_10_3389_fgene_2023_1152470
crossref_primary_10_1016_j_cca_2016_01_016
crossref_primary_10_1053_j_gastro_2022_10_036
crossref_primary_10_1080_1354750X_2016_1252961
crossref_primary_10_1002_advs_202309424
crossref_primary_10_1586_erm_13_37
crossref_primary_10_1053_j_gastro_2020_09_058
Cites_doi 10.1080/10408360802485875
10.1038/nature06008
10.1016/S1097-2765(03)00477-5
10.1016/S1097-2765(03)00479-9
10.1186/1759-8753-1-2
10.1128/MCB.01684-06
10.1016/j.cell.2007.05.009
10.1373/clinchem.2007.101766
10.1158/1078-0432.CCR-08-0869
10.1038/sj.emboj.7600545
10.1016/j.cca.2009.08.011
10.2174/156652410790963295
10.1016/j.tig.2004.08.008
10.1128/MCB.01529-06
10.1373/clinchem.2008.113597
10.1371/journal.pone.0006659
10.1038/ng1531
10.1093/clinchem/48.8.1212
ContentType Journal Article
Copyright International Society of Oncology and BioMarkers (ISOBM) 2012
International Society of Oncology and BioMarkers (ISOBM) 2013
Copyright_xml – notice: International Society of Oncology and BioMarkers (ISOBM) 2012
– notice: International Society of Oncology and BioMarkers (ISOBM) 2013
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7T5
7TO
7X7
7XB
88E
8AO
8C1
8FE
8FH
8FI
8FJ
8FK
8G5
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
GUQSH
H94
HCIFZ
K9.
LK8
M0S
M1P
M2O
M7P
MBDVC
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
Q9U
7X8
7TM
DOI 10.1007/s13277-012-0554-5
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Immunology Abstracts
Oncogenes and Growth Factors Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Public Health Database
ProQuest SciTech Collection
ProQuest Natural Science Collection
ProQuest Hospital Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Research Library
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
ProQuest Research Library
AIDS and Cancer Research Abstracts
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
ProQuest Health & Medical Collection
Medical Database
Research Library
Biological Science Database
Research Library (Corporate)
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
MEDLINE - Academic
Nucleic Acids Abstracts
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
Research Library Prep
ProQuest Central Student
Oncogenes and Growth Factors Abstracts
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
Research Library (Alumni Edition)
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central China
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Biological Science Collection
AIDS and Cancer Research Abstracts
ProQuest Research Library
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Public Health
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
Immunology Abstracts
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
Nucleic Acids Abstracts
DatabaseTitleList
Publicly Available Content Database
Nucleic Acids Abstracts
MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
EISSN 1423-0380
EndPage 336
ExternalDocumentID 2871343391
23086575
10_1007_s13277_012_0554_5
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
.GJ
06D
0VX
0VY
0~B
123
1N0
203
29Q
29~
2KM
2LR
2VQ
30V
30W
328
36B
3V.
4.4
408
40D
53G
67N
7X7
88E
8AO
8C1
8FE
8FH
8FI
8FJ
8G5
8UI
8UJ
96X
AAIAL
AAJKR
AARHV
AARTL
AASGM
AAWCG
AAYIC
AAYIU
AAYQN
AAYTO
AAYZH
AAZMS
ABBTS
ABJOX
ABPLI
ABQXT
ABTEG
ABTHY
ABTMW
ABUWG
ABWCG
ACBXY
ACGFS
ACKNC
ACPQW
ACPRK
ACQXL
ADAGL
ADBBV
ADHIR
ADINQ
ADKPE
ADZMO
AEGNC
AEJHL
AENEX
AEOHA
AEPYU
AETCA
AEWDL
AEYAO
AFBBN
AFCOW
AFDXO
AFKRA
AFKRG
AFLOW
AFRWT
AFSIO
AFWTZ
AFZKB
AGAYW
AGJBK
AGQMX
AGWZB
AGYKE
AHAVH
AHBYD
AHMBA
AHSBF
AHYZX
AIIXL
AIOMO
AJBLW
AJUZI
AKMHD
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
ANMIH
AUTPY
AYAKG
AZQEC
BBNVY
BCNDV
BDDNI
BENPR
BGNMA
BHPHI
BPHCQ
BSEHC
BVXVI
CAG
CCPQU
COF
CS3
CSCUP
CYUIP
DU5
DV7
DWQXO
E0A
EBD
EBS
EJD
EMB
EMOBN
EN4
ESBYG
F5P
FB.
FRRFC
FYJPI
FYUFA
GGRSB
GNUQQ
GQ6
GQ7
GROUPED_DOAJ
GROUPED_SAGE_PREMIER_JOURNAL_COLLECTION
GUQSH
H13
HCIFZ
HF~
HMCUK
HMJXF
HRMNR
HZ~
IOS
ITM
J0Z
J8X
JBSCW
K.F
KOV
LK8
M1P
M2O
M4Y
M7P
N9A
NQS
NU0
O1H
O9-
O93
O9I
OK1
PADUT
PIMPY
PQQKQ
PROAC
PSQYO
Q2X
R9I
RIG
RKO
ROL
RSV
RXVBD
S1Z
S27
S3A
S3B
SAUOL
SBL
SFC
SHX
SOJ
SV3
T13
U2A
U9L
UDS
UG4
UJ6
UKHRP
VC2
W48
WK8
Z45
ZOVNA
ZXP
~A9
0R~
AAYXX
ABFSG
ACHEB
ACSTC
AEZWR
AFHIU
AHWEU
AIXLP
CITATION
PHGZM
PHGZT
SCNPE
CGR
CUY
CVF
ECM
EIF
NPM
PJZUB
PPXIY
PQGLB
7T5
7TO
7XB
8FK
H94
K9.
MBDVC
PKEHL
PQEST
PQUKI
PRINS
PUEGO
Q9U
7X8
7TM
ID FETCH-LOGICAL-c405t-7cbce9e23a4176a2519f3c00b596a09def589876da4d1d8c3623af35e5e2d2e93
IEDL.DBID U2A
ISSN 1010-4283
1423-0380
IngestDate Fri Jul 11 09:52:17 EDT 2025
Fri Jul 11 03:19:20 EDT 2025
Sat Aug 23 14:57:58 EDT 2025
Mon Jul 21 06:02:14 EDT 2025
Thu Apr 24 22:57:34 EDT 2025
Tue Jul 01 02:37:11 EDT 2025
Fri Feb 21 02:38:42 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Circulating nucleosomes
Histone methylation
High-throughput nucleotide sequencing
Colorectal cancer
Language English
License http://www.springer.com/tdm
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c405t-7cbce9e23a4176a2519f3c00b596a09def589876da4d1d8c3623af35e5e2d2e93
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 14
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://www.proquest.com/docview/1271881314?pq-origsite=%requestingapplication%
PMID 23086575
PQID 1271881314
PQPubID 33651
PageCount 8
ParticipantIDs proquest_miscellaneous_1315622460
proquest_miscellaneous_1273700507
proquest_journals_1271881314
pubmed_primary_23086575
crossref_primary_10_1007_s13277_012_0554_5
crossref_citationtrail_10_1007_s13277_012_0554_5
springer_journals_10_1007_s13277_012_0554_5
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2013-02-01
PublicationDateYYYYMMDD 2013-02-01
PublicationDate_xml – month: 02
  year: 2013
  text: 2013-02-01
  day: 01
PublicationDecade 2010
PublicationPlace Dordrecht
PublicationPlace_xml – name: Dordrecht
– name: United States
– name: London
PublicationSubtitle Tumor Markers, Tumor Targeting and Translational Cancer Research
PublicationTitle Tumor biology
PublicationTitleAbbrev Tumor Biol
PublicationTitleAlternate Tumour Biol
PublicationYear 2013
Publisher Springer Netherlands
Springer Nature B.V
Publisher_xml – name: Springer Netherlands
– name: Springer Nature B.V
References Fraga, Ballestar, Villar-Garea, Boix-Chornet, Espada, Schotta (CR5) 2005; 37
Kim, Kiefer, Dean (CR17) 2007; 27
Martens, O'Sullivan, Braunschweig, Opravil, Radolf, Steinlein, Jenuwein (CR14) 2005; 24
Deligezer, Akisik, Erten, Dalay (CR4) 2008; 54
Beck, Urnovitz, Riggert, Clerici, Schütz (CR13) 2009; 55
CR19
Rice, Briggs, Ueberheide, Barber, Shabanowitz, Hunt (CR8) 2003; 12
Holdenrieder, Stieber (CR2) 2009; 46
Vakoc, Sachdeva, Wang, Blobel (CR18) 2006; 26
Ng, Tsui, Lam, Chiu, Yu, Wong (CR3) 2002; 48
Nikolaev, Iseli, Sharp, Robyr, Rougemont, Gehrig (CR21) 2009; 4
Leszinski, Gezer, Siegele, Stoetzer, Holdenrieder (CR11) 2012; 32
van der Vaart, Semenov, Kuligina (CR12) 2009; 409
Peters, Kubicek, Mechtler, O'Sullivan, Derijck, Perez-Burgos (CR7) 2003; 12
van den Broeck, Brambilla, Moro-Sibilot, Lantuejoul, Brambilla, Eymin (CR6) 2008; 14
Barski, Cuddapah, Cui, Roh, Schones, Wang (CR9) 2007; 129
Huda, Mariño-Ramírez, Jordan (CR16) 2010; 1
Vlassov, Laktionov, Rykova (CR1) 2010; 10
Deligezer, Akisik, Akisik, Kovancilar, Bugra, Erten, Gahan (CR10) 2011
Mikkelsen, Ku, Jaffe, Issac, Lieberman, Giannoukos (CR15) 2007; 448
Rudd, Willard (CR20) 2004; 20
U Deligezer (554_CR4) 2008; 54
A Broeck van den (554_CR6) 2008; 14
A Huda (554_CR16) 2010; 1
U Deligezer (554_CR10) 2011
VV Vlassov (554_CR1) 2010; 10
MF Fraga (554_CR5) 2005; 37
JC Rice (554_CR8) 2003; 12
A Barski (554_CR9) 2007; 129
S Holdenrieder (554_CR2) 2009; 46
EK Ng (554_CR3) 2002; 48
AH Peters (554_CR7) 2003; 12
JH Martens (554_CR14) 2005; 24
M Vaart van der (554_CR12) 2009; 409
MK Rudd (554_CR20) 2004; 20
A Kim (554_CR17) 2007; 27
G Leszinski (554_CR11) 2012; 32
J Beck (554_CR13) 2009; 55
CR Vakoc (554_CR18) 2006; 26
TS Mikkelsen (554_CR15) 2007; 448
554_CR19
SI Nikolaev (554_CR21) 2009; 4
15475110 - Trends Genet. 2004 Nov;20(11):529-33
19107649 - Crit Rev Clin Lab Sci. 2009;46(1):1-24
19684856 - PLoS One. 2009 Aug 17;4(8):e6659
18974389 - Clin Cancer Res. 2008 Nov 15;14(22):7237-45
18487283 - Clin Chem. 2008 Jul;54(7):1125-31
17512414 - Cell. 2007 May 18;129(4):823-37
14690610 - Mol Cell. 2003 Dec;12(6):1591-8
19181738 - Clin Chem. 2009 Apr;55(4):730-8
14690609 - Mol Cell. 2003 Dec;12(6):1577-89
15678104 - EMBO J. 2005 Feb 23;24(4):800-12
17158930 - Mol Cell Biol. 2007 Feb;27(4):1271-9
15765097 - Nat Genet. 2005 Apr;37(4):391-400
17603471 - Nature. 2007 Aug 2;448(7153):553-60
22593510 - Anticancer Res. 2012 May;32(5):2199-205
20226072 - Mob DNA. 2010 Jan 25;1(1):2
12142376 - Clin Chem. 2002 Aug;48(8):1212-7
17030614 - Mol Cell Biol. 2006 Dec;26(24):9185-95
19699193 - Clin Chim Acta. 2009 Nov;409(1-2):21-7
20196731 - Curr Mol Med. 2010 Mar;10(2):142-65
References_xml – volume: 46
  start-page: 1
  year: 2009
  end-page: 24
  ident: CR2
  article-title: Clinical use of circulating nucleosomes
  publication-title: Crit Rev Clin Lab Sci.
  doi: 10.1080/10408360802485875
– volume: 32
  start-page: 2199
  year: 2012
  end-page: 2206
  ident: CR11
  article-title: Histone modifications H3K9me3 and H4K20me3 on circulating nucleosomes in cancer disease
  publication-title: Anticancer Res.
– volume: 448
  start-page: 553
  year: 2007
  end-page: 560
  ident: CR15
  article-title: Genome-wide maps of chromatin state in pluripotent and lineage-committed cells
  publication-title: Nature
  doi: 10.1038/nature06008
– ident: CR19
– volume: 12
  start-page: 1577
  year: 2003
  end-page: 1589
  ident: CR7
  article-title: Partitioning and plasticity of repressive histone methylation states in mammalian chromatin
  publication-title: Mol Cell.
  doi: 10.1016/S1097-2765(03)00477-5
– volume: 12
  start-page: 1591
  year: 2003
  end-page: 1598
  ident: CR8
  article-title: Histone methyltransferases direct different degrees of methylation to define distinct chromatin domains
  publication-title: Mol Cell.
  doi: 10.1016/S1097-2765(03)00479-9
– volume: 1
  start-page: 2
  year: 2010
  ident: CR16
  article-title: Epigenetic histone modifications of human transposable elements: genome defense versus exaptation
  publication-title: Mob DNA.
  doi: 10.1186/1759-8753-1-2
– start-page: 97
  year: 2011
  end-page: 103
  ident: CR10
  article-title: H3K9me3/H4K20me3 ratio in circulating nucleosomes as potential biomarker for colorectal cancer
  publication-title: Circulating nucleic acids in plasma and serum
– volume: 27
  start-page: 1271
  year: 2007
  end-page: 1279
  ident: CR17
  article-title: Distinctive signatures of histone methylation in transcribed coding and noncoding human beta-globin sequences
  publication-title: Mol Cell Biol.
  doi: 10.1128/MCB.01684-06
– volume: 129
  start-page: 823
  year: 2007
  end-page: 837
  ident: CR9
  article-title: High-resolution profiling of histone methylations in the human genome
  publication-title: Cell.
  doi: 10.1016/j.cell.2007.05.009
– volume: 54
  start-page: 1125
  year: 2008
  end-page: 1131
  ident: CR4
  article-title: Sequence-specific histone methylation is detectable on circulating nucleosomes in plasma
  publication-title: Clin Chem.
  doi: 10.1373/clinchem.2007.101766
– volume: 14
  start-page: 7237
  year: 2008
  end-page: 7245
  ident: CR6
  article-title: Loss of histone H4K20 trimethylation occurs in preneoplasia and influences prognosis of non-small cell lung cancer
  publication-title: Clin Cancer Res.
  doi: 10.1158/1078-0432.CCR-08-0869
– volume: 24
  start-page: 800
  year: 2005
  end-page: 812
  ident: CR14
  article-title: The profile of repeat-associated histone lysine methylation states in the mouse epigenome
  publication-title: EMBO J.
  doi: 10.1038/sj.emboj.7600545
– volume: 409
  start-page: 21
  year: 2009
  end-page: 27
  ident: CR12
  article-title: Characterization of circulating DNA by parallel tagged sequencing on the 454 platform
  publication-title: Clin Chim Acta.
  doi: 10.1016/j.cca.2009.08.011
– volume: 10
  start-page: 142
  year: 2010
  end-page: 165
  ident: CR1
  article-title: Circulating nucleic acids as a potential source for cancer biomarkers
  publication-title: Curr Mol Med.
  doi: 10.2174/156652410790963295
– volume: 20
  start-page: 529
  year: 2004
  end-page: 533
  ident: CR20
  article-title: Analysis of the centromeric regions of the human genome assembly
  publication-title: Trends Genet.
  doi: 10.1016/j.tig.2004.08.008
– volume: 26
  start-page: 9185
  year: 2006
  end-page: 9195
  ident: CR18
  article-title: Profile of histone lysine methylation across transcribed mammalian chromatin
  publication-title: Mol Cell Biol.
  doi: 10.1128/MCB.01529-06
– volume: 55
  start-page: 730
  year: 2009
  end-page: 738
  ident: CR13
  article-title: Profile of the circulating DNA in apparently healthy individuals
  publication-title: Clin Chem.
  doi: 10.1373/clinchem.2008.113597
– volume: 4
  start-page: e6659
  year: 2009
  ident: CR21
  article-title: Detection of genomic variation by selection of a 9 mb DNA region and high throughput sequencing
  publication-title: PLoS One.
  doi: 10.1371/journal.pone.0006659
– volume: 48
  start-page: 1212
  year: 2002
  end-page: 1217
  ident: CR3
  article-title: Presence of filterable and nonfilterable mRNA in the plasma of cancer patients and healthy individuals
  publication-title: Clin Chem.
– volume: 37
  start-page: 391
  year: 2005
  end-page: 400
  ident: CR5
  article-title: Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer
  publication-title: Nat Genet.
  doi: 10.1038/ng1531
– volume: 20
  start-page: 529
  year: 2004
  ident: 554_CR20
  publication-title: Trends Genet.
  doi: 10.1016/j.tig.2004.08.008
– volume: 24
  start-page: 800
  year: 2005
  ident: 554_CR14
  publication-title: EMBO J.
  doi: 10.1038/sj.emboj.7600545
– ident: 554_CR19
– volume: 26
  start-page: 9185
  year: 2006
  ident: 554_CR18
  publication-title: Mol Cell Biol.
  doi: 10.1128/MCB.01529-06
– volume: 14
  start-page: 7237
  year: 2008
  ident: 554_CR6
  publication-title: Clin Cancer Res.
  doi: 10.1158/1078-0432.CCR-08-0869
– volume: 12
  start-page: 1591
  year: 2003
  ident: 554_CR8
  publication-title: Mol Cell.
  doi: 10.1016/S1097-2765(03)00479-9
– volume: 48
  start-page: 1212
  year: 2002
  ident: 554_CR3
  publication-title: Clin Chem.
  doi: 10.1093/clinchem/48.8.1212
– volume: 409
  start-page: 21
  year: 2009
  ident: 554_CR12
  publication-title: Clin Chim Acta.
  doi: 10.1016/j.cca.2009.08.011
– volume: 1
  start-page: 2
  year: 2010
  ident: 554_CR16
  publication-title: Mob DNA.
  doi: 10.1186/1759-8753-1-2
– volume: 129
  start-page: 823
  year: 2007
  ident: 554_CR9
  publication-title: Cell.
  doi: 10.1016/j.cell.2007.05.009
– volume: 27
  start-page: 1271
  year: 2007
  ident: 554_CR17
  publication-title: Mol Cell Biol.
  doi: 10.1128/MCB.01684-06
– volume: 55
  start-page: 730
  year: 2009
  ident: 554_CR13
  publication-title: Clin Chem.
  doi: 10.1373/clinchem.2008.113597
– volume: 46
  start-page: 1
  year: 2009
  ident: 554_CR2
  publication-title: Crit Rev Clin Lab Sci.
  doi: 10.1080/10408360802485875
– volume: 10
  start-page: 142
  year: 2010
  ident: 554_CR1
  publication-title: Curr Mol Med.
  doi: 10.2174/156652410790963295
– volume: 32
  start-page: 2199
  year: 2012
  ident: 554_CR11
  publication-title: Anticancer Res.
– volume: 37
  start-page: 391
  year: 2005
  ident: 554_CR5
  publication-title: Nat Genet.
  doi: 10.1038/ng1531
– start-page: 97
  volume-title: Circulating nucleic acids in plasma and serum
  year: 2011
  ident: 554_CR10
– volume: 4
  start-page: e6659
  year: 2009
  ident: 554_CR21
  publication-title: PLoS One.
  doi: 10.1371/journal.pone.0006659
– volume: 12
  start-page: 1577
  year: 2003
  ident: 554_CR7
  publication-title: Mol Cell.
  doi: 10.1016/S1097-2765(03)00477-5
– volume: 448
  start-page: 553
  year: 2007
  ident: 554_CR15
  publication-title: Nature
  doi: 10.1038/nature06008
– volume: 54
  start-page: 1125
  year: 2008
  ident: 554_CR4
  publication-title: Clin Chem.
  doi: 10.1373/clinchem.2007.101766
– reference: 15765097 - Nat Genet. 2005 Apr;37(4):391-400
– reference: 19699193 - Clin Chim Acta. 2009 Nov;409(1-2):21-7
– reference: 12142376 - Clin Chem. 2002 Aug;48(8):1212-7
– reference: 15678104 - EMBO J. 2005 Feb 23;24(4):800-12
– reference: 20226072 - Mob DNA. 2010 Jan 25;1(1):2
– reference: 17158930 - Mol Cell Biol. 2007 Feb;27(4):1271-9
– reference: 19181738 - Clin Chem. 2009 Apr;55(4):730-8
– reference: 14690610 - Mol Cell. 2003 Dec;12(6):1591-8
– reference: 18974389 - Clin Cancer Res. 2008 Nov 15;14(22):7237-45
– reference: 22593510 - Anticancer Res. 2012 May;32(5):2199-205
– reference: 17512414 - Cell. 2007 May 18;129(4):823-37
– reference: 18487283 - Clin Chem. 2008 Jul;54(7):1125-31
– reference: 15475110 - Trends Genet. 2004 Nov;20(11):529-33
– reference: 14690609 - Mol Cell. 2003 Dec;12(6):1577-89
– reference: 17030614 - Mol Cell Biol. 2006 Dec;26(24):9185-95
– reference: 20196731 - Curr Mol Med. 2010 Mar;10(2):142-65
– reference: 19684856 - PLoS One. 2009 Aug 17;4(8):e6659
– reference: 19107649 - Crit Rev Clin Lab Sci. 2009;46(1):1-24
– reference: 17603471 - Nature. 2007 Aug 2;448(7153):553-60
SSID ssj0015996
Score 2.2259529
Snippet Modified histone tails in nucleosomes circulating in the blood bear the potential as cancer biomarkers. Recently, using chromatin immunopecipitation...
SourceID proquest
pubmed
crossref
springer
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 329
SubjectTerms Antibodies
Biomarkers
Biomarkers, Tumor - genetics
Biomedical and Life Sciences
Biomedicine
Blood
Cancer Research
Chromatin
Chromatin Immunoprecipitation
Colorectal cancer
Colorectal Neoplasms - blood
Colorectal Neoplasms - genetics
Deoxyribonucleic acid
DNA
DNA - blood
DNA Methylation
DNA sequencing
Female
Genomes
High-Throughput Nucleotide Sequencing
Histones
Histones - blood
Histones - genetics
Histones - metabolism
Humans
Interspersed Repetitive Sequences
Methylation
Middle Aged
Nucleosomes
Nucleosomes - genetics
Nucleotide sequence
Plasma
Plasma levels
Polymerase chain reaction
Proteins
Repeated DNA sequences
Research Article
Tumors
SummonAdditionalLinks – databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT9wwELZaKrVcUKG0LKXIlTiBrDp-JPGpQtuiVVE5FWlvkWM7FVJJln0cOPePd8brBBDqHqNMEiczmRn7G39DyElRaNFkuWe-NDlTkNCyEm1ZWV5b7jW3NrJ9XuWTa_VjqqdpwW2Ryip7nxgdte8crpF_yQR40TKTmfo6u2PYNQrR1dRC4yV5hdRlWNJVTIcJV4bUIxHtBF-DxGI9qhm3zkkELzkWJkBEZfppXHqWbD4DSmP8uXhLdlLiSM_Xmt4lL0K7R96M-35te-T1zwSTvyN_xwMN83qXJe0aOpGX5jZIRm3r6URdCo5HNqkneOpu5i4282p_0xZpjrtFdwuP_HZ1Tut7isTGLLX1ma2WNBVho_RNS5H8Gp0nyDs0pPk-ub74_ms8YanbAnOQtC1Z4WoXTBDSqqzILe5obaTjvNYmt9z40OjSgO_0VvnMlw4in7SN1EEH4UUw8j3Zars2HBCqNOYBHm4ShJK8NrUxAe6shDC5bviI8P5bVy5RkWNHjD_VA4kyqqcC9VSonkqPyOlwyWzNw7FJ-KhXYJV-yUX1YEAj8nk4DTpChMS2oVtFGVkgJU6xQUbClBdp-OA1PqyNYxgRzOdKRLJG5Ky3lkcD-N9wDzcP9yPZFrEHB9bQHJGt5XwVPkEmtKyPo7n_A7fPASY
  priority: 102
  providerName: ProQuest
Title Characterization of H3K9me3- and H4K20me3-associated circulating nucleosomal DNA by high-throughput sequencing in colorectal cancer
URI https://link.springer.com/article/10.1007/s13277-012-0554-5
https://www.ncbi.nlm.nih.gov/pubmed/23086575
https://www.proquest.com/docview/1271881314
https://www.proquest.com/docview/1273700507
https://www.proquest.com/docview/1315622460
Volume 34
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3da9RAEB9sC-pL0art1Xqs4JMS2OxHkn08z6uHh4eIB-dT2OxupGCTch8PPvcf70wuSZVqwZeEkMlmk5ndmeW38xuAN2mqRRknPvKZSSKFAW2UkS0rywvLvebWNmyf82S6UJ-Wetnmca-73e4dJNnM1LfJbpLgRk5bCdAHRnoPDjQt3dGIF2LUQwfEN9JAnDjBEJtYB2X-rYk_ndGdCPMOOto4nfMncNhGi2y0U-9TeBCqI3g07oq0HcHDzy02_gyuxz338i61ktUlm8qZuQwyYrbybKpmgtOVbXUSPHMXK9dU8Kp-sIq4jet1fYmv_DAfseIXIzbjqK3lc7XdsHbnNUlfVIwYr2nGRHlH1rN6DovzybfxNGpLLEQOI7VNlLrCBROEtCpOE0tprKV0nBfaJJYbH0qdGZwwvVU-9plDdydtKXXQQXgRjHwB-1VdhRNgSpPz99hIEErywhTGBGxZCWESXfIB8O5f567lH6cyGD_zW-ZkUk-O6slJPbkewNv-kasd-cZ9wmedAvN2HK7zWKDvzWIZqwG87m-jjggWsVWot42MTIkHJ71HRuI6l7j38DOOd8bR9wgXcRnBVwN411nLbx34V3dP_0v6JTwWTR0O2kdzBvub1Ta8wmhoUwxhL12meMzG8RAORh-_zyZ4fj-Zf_k6bEbGDbfhApM
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB5VqUS5ICivQIFFggvIYr0PPw4IlbRVStoIoVbqzax316gStUMeQj3zf_iNzPhVUEVuPVqerDeZz7Mz-Xa_AXgVx1oUYeQCl6RRoDChDRLCsjI8N9xpbkyt9jmNxqfq05k-24Df3VkY2lbZxcQ6ULvK0n_k70KBUTQJZag-zH4E1DWK2NWuhUYDi4m__Ikl2-L94R7697UQB_sno3HQdhUILCYnyyC2ufWpF9KoMI4MndwspOU812lkeOp8oRMsxCNnlAtdYjHCS1NI7bUXTngSX8KQv6kkljID2Py4P_38pectSOyk5lcxupGUWcej1of1JNGlnLZC4Boe6H9Xwmvp7TVqtl7xDu7CnTZVZbsNtu7Bhi-3YWvUdYjbhlvHLTF_H36NeuHn5lwnqwo2lpP0wsuAmdKxsZoITlemBYR3zJ7Pbd0-rPzGShJWrhbVBT5yb7rL8ktGUspB20hotlqydts3WZ-XjOS2KVyjvSXozh_A6Y144iEMyqr0j4EpTZmHw0G8UJLnaZ6mHkdWQqSRLvgQePdbZ7YVP6ceHN-zK9lmck-G7snIPZkewpv-I7NG-WOd8U7nwKwNAovsCrJDeNnfRh8RJ2NKX61qGxmTCE-8xkZikU3Cf_g1HjXg6GeEFWRC3NkQ3nZo-WsC_5vuk_XTfQFb45Pjo-zocDp5CrdF3QGEdvDswGA5X_lnmIct8-ct-Bl8ven37Q-IRz-d
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELagSIULgvJaKGAkTiCrjh9JfFxtWS0srDiwUm-RYztVJeqsdrMHzvxxZvIqqFCJY5SJ42TGnrG-mW8IeZtlWlRJ6pnPTcoUBLQsR1tWlpeWe82tbdk-V-lirT6d6bO-z-luyHYfIMmupgFZmmJzsvHVyVXhm0TokWNaAfhDpm-TO7AbJ2jWazEdYQTkHmnhTthskFlsgDX_NsSfjulatHkNKW0d0PwBud9HjnTaqfohuRXiEbk7Gxq2HZHDLz1O_oj8nI08zF2ZJa0rupBLcxkkozZ6ulBLwfHK9voJnrqLrWu7ecVzGpHnuN7Vl_DK09WUlj8oMhuzvq_PZt_QPgsbpS8iRfZr3D1B3qElbR-T9fzDt9mC9e0WmIOorWGZK10wQUirkiy1WNJaScd5qU1qufGh0rmBzdNb5ROfO3B90lZSBx2EF8HIJ-Qg1jE8I1RpDAQ8DBKEkrw0pTEBRlZCmFRXfEL48K8L13ORY0uM78UVizKqpwD1FKieQk_Iu_GRTUfEcZPw8aDAol-TuyIR4IdzsBI1IW_G26AjhEhsDPW-lZEZcuJkN8hIOPMiDx98xtPOOMYZwYEuRyhrQt4P1vLbBP413ef_Jf2aHH49nRefP66WL8g90bbnwPSaY3LQbPfhJQRJTfmqXQi_AKHvBOA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Characterization+of+H3K9me3-+and+H4K20me3-associated+circulating+nucleosomal+DNA+by+high-throughput+sequencing+in+colorectal+cancer&rft.jtitle=Tumor+biology&rft.au=Gezer%2C+Ugur&rft.au=Ustek%2C+Duran&rft.au=Y%C3%B6r%C3%BCker%2C+Ebru+E&rft.au=Cakiris%2C+Aris&rft.date=2013-02-01&rft.eissn=1423-0380&rft.volume=34&rft.issue=1&rft.spage=329&rft_id=info:doi/10.1007%2Fs13277-012-0554-5&rft_id=info%3Apmid%2F23086575&rft.externalDocID=23086575
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1010-4283&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1010-4283&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1010-4283&client=summon